Released Nov 14, 2024, after the close
10-Q filed Nov 14, 2024, 45 days after period end · 0001437749-24-035311
Q3 2024 · 10-Q
Revenue$2.51M$2.51M +22.1% vs Q3 2023+35.6% vs Q2 2024
Net Income-$1.46M-$1.46M N/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$0.02-$0.02 no prior Q3 2023 on fileno prior Q2 2024 on file
Gross Profit$1,836,220+22.1%
Operating Income-$1,469,179N/M
Operating Cash Flowderived-$973,914N/M
Margins · derived
Gross margin73.0%+0.0 pt vs Q3 2023
Operating margin-58.4%+14.7 pt vs Q3 2023
Net margin-58.1%+13.1 pt vs Q3 2023
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $2.51M | $2.06M | $2.22M | $2.11M |
| Net Income | -$1.46M | -$1.47M | -$1.97M | -$2.04M |
| EPS Diluted | -$0.02 | — | -$0.03 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Scientific Inc. · CIK 855683 · Engraved from SEC EDGAR